Rheumatologists Are Eager To Use Roche-Genentech's ACTEMRA, According To New Study By BioTrends
Links shared publicly online about this topic.
- 1,303total visits
Rheumatologists Are Eager To Use Roche-Genentech's ACTEMRA, According To New Study By BioTrends
BioTrends is pleased to announce the publication of a new syndicated report, LaunchTrends®: ACTEMRA. Actemra (tocilizumab), marketed by Roche-Genentech, is the first IL-6 recept
View full resource at medicalnewstoday.com
Tags: Arthritis, Rheumatoid Arthritis Medication, Actemra, Rheumatologist, Rheumatology
Most Recently Shared on March 19, 2010 at 3:07 pm By:
Rheumatologists Are Eager To Use Roche-Genentech's ACTEMRA, According To New Study By BioTrends http://mnt.to/3z9s #pharma #pharmaceutical
Also Shared By:
Advertisement
MNT Arthritis News
@mnt_arthritis
Rheumatologists Are Eager To Use Roche-Genentech's ACTEMRA, According To New Study By BioTrends http://mnt.to/3z9s #arthritis
1 year ago...